According to a drug trial that was presented at the American College of Rheumatology in San Francisco indicates that methotrexate, when used in combination with tocilizumab, resulted in remission in 47% of the patients. This compares to only 8% for patients on methotrexate [...]
|
|||||||
 |
The foods you eat have a significant impact on how well your body functions. For arthritis sufferers, an anti-inflammatory diet may be the best choice. So what is an anti-inflammatory diet? It depends on who you [...] Pfizer announced last Friday that they have agreed to pay $894 million to settle 3 lawsuits that alleged Celebrex and Bextra harmed patients in the U.S. and defrauded consumers. The suits claimed that Bextra and Celebrex resulted in increased risks of heart attacks and [...] This analysis found that during the year following the halt of the 2004 study the risk of heart attack was 94% higher for those that took Vioxx (34) over those that took the placebo (18). They also found that the risk of stroke was more that double for the Vioxx group (19) over the placebo group [...] |
  
|
|||||
|
Copyright © 2010 Current Arthritis News and Research - All Rights Reserved
|
|||||||
Recent Comments